Photo highlights from ExL Pharma's September Conference: Merging eHR & EDC.
Participants from the pharmaceutical industry, HIT, EDC, NIH, and academia gathered in Washington, DC in September to explore, discuss, debate, and resolve present issues confronting and challenging the use of electronic health records (eHR) and electronic data capture (EDC) in clinical research.
Day One of ExL Pharma's "Merging eHR & EDC" Conference began with a hearty discussion of whether eHR and EDC can be merged. The discussion flowed well into Day Two's presentations on practical approaches to implementation and convergence.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
First Patient Dosed in Phase III Trial of Enhertu as First-Line Treatment for Endometrial Cancer
June 10th 2025In combination with rilvegostomig or Keytruda, Enhertu will be evaluated versus chemotherapy in the DESTINY-Endometrial01 study for the treatment of patients with HER2-expressing, mismatch repair proficient primary advanced or recurrent endometrial cancer.